Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.59
06.02.22
-
06.02.23
-5.93%
20.02.22

buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€6.22
06.02.22
-
06.02.23
-15.28%
20.02.22

Risky Investment
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€9.99
06.02.22
-
06.02.23
-11.31%
20.02.22

buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€11.22
06.02.22
-
06.02.23
-1.52%
20.02.22

buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€2.53
06.02.22
-
06.02.23
-8.76%
20.02.22

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.03
05.02.22
€20.00
05.02.23
-57.41%
06.02.23

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
buy
Conatus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.53
05.02.22
-
05.02.23
-
06.02.23

buy
Acer Therapeutics Inc

Start price
Target price
Perf. (%)
€1.88
05.02.22
-
05.02.23
7.61%
06.02.23

buy
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.23
05.02.22
€3.00
05.02.23
21.14%
19.02.22

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€5.75
05.02.22
€10.00
05.02.23
21.74%
19.02.22

buy
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€11.10
05.02.22
€20.00
05.02.23
5.41%
19.02.22

buy
Neovacs

Start price
Target price
Perf. (%)
€25,296
05.02.22
€48,000
05.02.23
-40.54%
19.02.22

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.68
05.02.22
€2.00
05.02.23
10.12%
19.02.22

buy
BiondVax Pharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€0.40
04.02.22
-
-
06.02.22

Risky Investment
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.78
04.02.22
€46.00
04.02.23
18.67%
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
Theranexus

Start price
Target price
Perf. (%)
€3.18
04.02.22
€36.00
04.02.23
-41.98%
05.02.23

Could be worthwhile Investment >10% per year
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€7.92
03.02.22
€14.00
03.02.23
-80.80%
14.01.23

Bayer AG

Start price
Target price
Perf. (%)
€53.28
03.02.22
-
03.02.23
-3.55%
21.02.22

buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.04
02.02.22
-
02.02.23
-4.33%
06.02.22

Risky Investment
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.66
02.02.22
-
02.02.23
-3.83%
06.02.22

Risky Investment
buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€9.30
02.02.22
-
02.02.23
-2.26%
06.02.22

Risky Investment
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€78.53
02.02.22
€90.00
02.02.23
-2.20%
03.02.22

buy
Evotec SE

Start price
Target price
Perf. (%)
€37.20
02.02.22
-
02.02.23
-48.63%
03.02.23

buy
Evotec SE

Start price
Target price
Perf. (%)
€36.65
01.02.22
€44.00
01.08.22
-30.83%
01.08.22

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€87.29
01.02.22
-
01.02.23
-88.23%
02.02.23

Could be worthwhile Investment >10% per year
Fair valuation
Revenue growth >5% per year expected
Standard Investments for future growth